Add BrightSurf on Google Email

New editorial urges clinicians to address sex-based disparities in sepsis treatment

The editorial highlights how biological sex and gender inequities contribute to suboptimal sepsis treatment, potentially compromising outcomes for women. Hormonal fluctuations, body composition, and renal clearance all influence drug processing, yet these variables are rarely considered in dosing algorithms.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeCommentary/editorial·DateOct 31, 2025

Call grows to individualize fluid therapy in septic shock

The article argues that a universal 30 mL/kg fluid bolus is no longer appropriate and instead calls for a balanced, individualized approach to fluid management in septic shock. This approach considers the patient's comorbidities, infection source, and estimated fluid losses, and guides management by frequent reassessment.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeCommentary/editorial·DateOct 30, 2025

Moderate-dose corticosteroid treatment improves patient recovery rates from sepsis

A study published in the Journal of Intensive Medicine found that moderate-dose corticosteroids improve sepsis patient recovery rates by stabilizing immune cells and reducing inflammation. The treatment also shows protective effects on the heart and vascular system, preventing cardiovascular failure and organ damage.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeSystematic review·DateOct 16, 2025

Immune cell ‘signatures’ could help guide treatment for critically ill patients

Researchers developed a collection of blood tests that assess genetic activity patterns in immune cells to reveal patient immune states. These tests could help physicians determine diagnosis and care protocols for patients with suspected infections or critical conditions, providing more accurate diagnoses and treatment guidance.

SourceStanford Medicine·JournalNature Medicine·TypeExperimental study·DateSep 30, 2025

‘Alarming’ rise in newborn babies with antibiotic-resistant infections, researchers find

A study published in The Lancet Regional Health – Western Pacific found that most newborn infections in Southeast Asia are caused by bacteria unlikely to respond to current treatments, highlighting the need for updated diagnostic and treatment guidelines. Locally relevant data is crucial for guiding routine medical decisions, and new a...

SourceUniversity of Sydney·JournalThe Lancet Regional Health - Western Pacific·TypeObservational study·DateSep 29, 2025

UH Rainbow’s Dr. Charles Macias and the Improving Pediatric Sepsis Outcomes Collaborative honored with John M. Eisenberg Award

The Improving Pediatric Sepsis Outcomes Collaborative has received the prestigious John M. Eisenberg Award, recognizing outstanding leadership and innovation in reducing pediatric sepsis mortality. The award highlights programs demonstrating impact, innovation, sustainability, replicability, and data-driven success.

Spectacular breakthrough in sepsis research: Vitamin B1 stops deadly lactate production and opens the door to a new treatment

Researchers discover vitamin B1 restores mitochondrial energy metabolism, drastically reducing lactate production and increasing survival rates in sepsis. The combination of vitamin B1 and glucose proves to be an effective treatment, promising hope for patients affected by this deadly condition.

SourceVlaams Instituut voor Biotechnologie·JournalCell Reports·DateJul 29, 2025

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

A new study has identified specific proteins in umbilical cord blood that signal acute systemic inflammation, providing a non-invasive means to diagnose early onset sepsis in preterm newborns. This discovery could lead to the development of a diagnostic test to avoid prolonged antibiotic exposure for infants at risk.

Rediscovering the first known cellular receptor

Researchers have reexamined the Ashwell-Morell receptor's functions using innovative glycoengineering techniques, clarifying its roles in sepsis and inflammation control. The study reveals that the receptor can bind to a specific type of protein glycan chain, which was previously thought to be incompatible with binding.

SourceSanford Burnham Prebys·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 14, 2025

Study findings raise questions about the inclusion of sepsis bundle in the CMS value program

A systematic review found no moderate-to-high level evidence that compliance with the Centers for Medicare & Medicaid Services' (CMS) Severe Sepsis and Septic Shock Management Bundle was associated with improved sepsis mortality. The study suggests reconsidering the inclusion of the bundle in the Hospital Value-Based Purchasing program.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateFeb 17, 2025

Sepsis, or death by lethal message

Researchers discovered that cells caught up in sepsis send out messages to other cells, causing them to die and fueling the spiraling inflammation. By understanding this process, scientists may be able to develop a treatment for inflammatory diseases like sepsis.

SourceUniversity of Connecticut·JournalCell·TypeExperimental study·DateJan 24, 2025

Boosting this molecule could help retain muscle while losing fat

A new study from the Salk Institute has discovered that a protein called BCL6 plays a crucial role in maintaining healthy muscle mass. Increasing BCL6 levels successfully reversed muscle losses in mice, suggesting that pairing GLP-1 medications with a BCL6-boosting drug could help counteract unwanted muscle loss.

SourceSalk Institute·JournalProceedings of the National Academy of Sciences·DateJan 23, 2025

Non-invasive imaging tests may lead to early sepsis detection

Researchers have developed a non-invasive strategy that assesses blood flow through skeletal muscle to detect early signs of sepsis. The technique, combining hyperspectral near-infrared spectroscopy and diffuse correlation spectroscopy, was tested in rodents and detected sepsis before vital organs were affected.

SourceWiley·JournalThe FASEB Journal·DateDec 4, 2024

ASU researchers gain insight into how a deadly strain of salmonella fine-tunes its infection tactics

Researchers have gained insight into how a deadly strain of salmonella adapts to invasion, flourishing in hostile environments and evading immune defenses. The study sheds light on the role of fluid shear forces in bacterial behavior, which may accelerate the design of new therapies for life-threatening infections.

SourceArizona State University·JournalGut Microbes·TypeExperimental study·DateJun 14, 2024

BU study finds policy makers’ use of in-hospital mortality as a sepsis quality metric may unfairly penalize safety-net hospitals

A Boston University study suggests that in-hospital mortality for patients with sepsis may not accurately reflect true short-term mortality rates, potentially harming safety-net hospitals. The researchers found no difference in 30-day mortality between safety-net and non-safety-net hospitals, contrary to previous reports.

SourceBoston University School of Medicine·JournalJAMA Network Open·TypeData/statistical analysis·DateMay 31, 2024

Nationwide study reveals burden and geographic patterns of sepsis among hospitalized non-child cancer patients in China

A nationwide study found a high incidence rate of sepsis cases among non-child cancer patients in China, with males exhibiting higher rates than females. The study also revealed significant geographic variations in sepsis burden across China, with regions having lower and higher development levels exhibiting elevated rates.

SourceScience China Press·JournalScience Bulletin·DateMay 24, 2024

Chinese Medical Journal review explores cell-based immunotherapies for sepsis

Researchers review cell-based therapies for comprehensive sepsis management, highlighting the potential of mesenchymal stem cells and innate immune cells like macrophages. The review also emphasizes the need for further studies on optimal dosage, administration routes, and storage methods to maximize efficacy and safety.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateMay 16, 2024